APGN
Apexigen, Inc. Common Stock
stockNASDAQ

Latest News

Sep 25, 2026

07:23 AM EDTXinhua Silk Road: Zhejiang's Yandangshan in E China expands partnerships with more int'l peers · PR Newswire

apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company's proprietary antibody drug discovery platform. its lead immuno-oncology drug candidate, apx005m, is a potent immune-activating antibody against cd40 currently in phase 2 clinical development.